Literature DB >> 19366838

'Islands' and 'doctor's tool': the ethical significance of isolation and subordination in UK community pharmacy.

R J Cooper1, P Bissell, J Wingfield.   

Abstract

Empirical ethics research is increasingly valued in offering insights into how ethical problems and decision-making occur in healthcare. In this article, the findings of a qualitative study of the ethical problems and decision-making of UK community pharmacists are presented, and it is argued that the identified themes of pharmacists' relative isolation from others and their subordination to doctors are ethically significant. Semi-structured interviews were conducted with 23 community pharmacists in England, UK. Analysis of interviews revealed that isolation involved separation of pharmacists from their peers, other healthcare professionals, patients and customers. Such isolation is argued to be inimical to ethical practice - impeding ethical discourse as understood by Habermas, resulting in a form of anomie that inhibits the transmission of professional values, leading to a lack of proximity between pharmacist and patient or customer that may impede ethical relationships and resulting, psychologically, in less ethical concern for those who are less close. Pharmacists' subordination to doctors not only precipitated some ethical problems but also allowed some pharmacists to shift ethical responsibility to a prescribing doctor, as in the case of emergency hormonal contraception. The emergence of atrocity stories further supports a culture of subordination that may cause ethical problems. The study has implications for community pharmacy practice in terms of supervision issues, developments such as prescribing responsibilities and how ethical values can be taught and communicated. The potential for isolation and subordination in other healthcare professions, and resultant ethical problems, may also need to be addressed and researched.

Entities:  

Mesh:

Year:  2009        PMID: 19366838     DOI: 10.1177/1363459308101805

Source DB:  PubMed          Journal:  Health (London)        ISSN: 1363-4593


  8 in total

1.  Exploring communications around medication review in community pharmacy.

Authors:  Susanne Kaae; Ellen Westh Sørensen; Lotte Stig Nørgaard
Journal:  Int J Clin Pharm       Date:  2011-03-26

2.  Insights From the Defining Issues Test on Moral Reasoning Competencies Development in Community Pharmacists.

Authors:  Cicely Roche; Steve Thoma
Journal:  Am J Pharm Educ       Date:  2017-10       Impact factor: 2.047

3.  Evaluation of a Danish pharmacist student-physician medication review collaboration model.

Authors:  Susanne Kaae; Ellen Westh Sørensen; Lotte Stig Nørgaard
Journal:  Int J Clin Pharm       Date:  2014-04-27

4.  Community pharmacist perception and attitude toward ethical issues at community pharmacy setting in central Saudi Arabia.

Authors:  Mohamed N Al-Arifi
Journal:  Saudi Pharm J       Date:  2013-09-11       Impact factor: 4.330

5.  Moral reasoning among Dutch community pharmacists: testing the applicability of the Australian Professional Ethics in Pharmacy test.

Authors:  M Kruijtbosch; W Göttgens-Jansen; A Floor-Schreudering; E van Leeuwen; M L Bouvy
Journal:  Int J Clin Pharm       Date:  2019-06-28

6.  Assessment of Community Pharmacy Professionals' Attitude and Perception Towards Ethical Issues in Amhara Region, Ethiopia: A Cross-Sectional Survey 2020.

Authors:  Wudneh Simegn; Berhanemeskel Weldegerima; Alem Endeshaw; Gashaw Sisay; Abdulwase Mohammed; Dawit Wondimsigegn; Henok Dagne
Journal:  Risk Manag Healthc Policy       Date:  2021-10-02

7.  Professional Use of Social Media by Pharmacists: A Qualitative Study.

Authors:  Arcelio Benetoli; Timothy Frank Chen; Marion Schaefer; Betty B Chaar; Parisa Aslani
Journal:  J Med Internet Res       Date:  2016-09-23       Impact factor: 5.428

8.  Moral dilemmas of community pharmacists: a narrative study.

Authors:  Martine Kruijtbosch; Wilma Göttgens-Jansen; Annemieke Floor-Schreudering; Evert van Leeuwen; Marcel L Bouvy
Journal:  Int J Clin Pharm       Date:  2017-11-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.